Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,166.8
-16.2 (-0.51%)

 

  • STI Straits Times Index
    3,166.8
    -16.2 (-0.51%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.5
    -4.8 (-0.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,754.1
    -36.1 (-0.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,985.7
    7.5 (0.25%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,960.7
    -40.6 (-0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,276.6
    39.9 (0.64%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,070.7
    8.4 (0.41%)
    Index delayed 20 minutes
  • XAO XAO
    6,791.2
    -10.5 (-0.15%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 726.6M
  • Value: 896.1M
  • Rise: 134
  • Fall: 155
  • Unch: 544

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.088-0.005
TEE Intl0.046+0.004
YZJ Shipbldg SGD1.050-0.030
Spackman0.013+0.001
Mapletree Ind Tr2.400+0.070
Keppel DC Reit1.970+0.040
Kep Infra Tr0.525+0.005
LionGold0.001-
Medtecs Intl0.039+0.007
Mapletree Com Tr2.220+0.060

World Indices

World Indices
Name Last Change
Nasdaq 8,186.0 +32.5
HSI 26,754.1 -36.1
HSCEI 10,478.5 -23.9
Jakarta 6,276.6 +39.9
Nikkei 225 21,960.7 -40.6
SSE Comp 2,985.7 +7.5
Shanghai A 3,127.8 +7.9
Shanghai B 271.6 +0.9
PSE Comp 0.0
KOSPI 2,070.7 +8.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CYNATA THERAPEUTICS LTD CYNATA THERAPEUTICS
Updated on 17 Sep 2019 (End of trading day)
Last (AUD): 1.420 Change: - High: 1.420 Remarks: -
Change (%): - Low: 1.420
Open 1.420 Yesterday's Close 1.42
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.08279 Trailing EPS (AUD) e -0.08279 NAV (AUD) b 0.1072
PE a - Trailing PE f - Price / NAV b 13.2463
Dividend (AUD) d - Cash In Hand (AUD) g 0.0682 Issued & Paid-up Shares c 102,335,000
Dividend Yield (%) d - Price / Cash In Hand g 20.821 Treasury Shares h -
Beta - 75 Daysi 1.021 R-Squared - 75 Days(%)i 5.39 Market Cap (M) 145.316
Beta - 500 Daysi 0.606 R-Squared - 500 Days (%)i 1.18 Enterprise Value (M) 138.339
Piotroski F Score 1 Exchange Code CYP Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 61.50 Free Float (%) 74.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CYNATA THERAPEUTICS LTD ASX 145.316 - - 13.2463 -
Industry Biotechnology ASX 2,255.288 49.410 49.218 13.0213 1.068
Local Peer CSL ASX 106,410.911 39.662 39.662 14.2200 1.132
Local Peer POLYNOVO LIMITED ASX 1,434.561 - - 54.9367 -
Local Peer MESOBLAST LTD ASX 1,074.497 - - 1.5675 -
Local Peer AVITA MEDICAL LTD ASX 973.898 - - 32.0988 -
Local Peer NEXT SCIENCE LTD ASX 565.893 - - 16.2648 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 431.196 - - 10.1665 -
Local Peer TELIX PHARMACEUTIC ASX 382.003 - - 8.8407 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 210.467 68.479 - 12.5461 -
Local Peer RESAPP HEALTH LIMITED ASX 142.732 - - 18.6364 -
Local Peer PHYLOGICA LIMITED ASX 114.814 - - 18.0769 -
Local Peer IMUGENE LIMITED ASX 83.027 - - 3.0263 -
Local Peer IMMUTEP LTD ASX 81.191 - - -4.7727 -
Other Local Peers ORTHOCELL LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), BIOTRON (ASX), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NOVITA HEALTHCARE LTD (ASX), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 117,973.181 14.054 14.824 10.9295 2.818
Global Peer GILEAD SCIENCES INC NASDAQ 83,800.996 15.362 14.072 3.7054 3.488
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CELGENE CORP NASDAQ 69,881.863 17.272 13.258 6.9527 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,238.160 21.579 20.424 8.9228 -
Global Peer ILLUMINA INC NASDAQ 43,845.690 53.082 46.744 10.1213 -
Global Peer BIOGEN INC NASDAQ 44,027.499 9.937 8.316 3.3990 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 31,662.760 12.953 15.302 3.2455 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,178.397 311.575 18.130 2.3789 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,643.355 74.821 22.055 4.9807 0.802
Other Global Peers SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), WUXI BIO (HKEx), SEATTLE GENETICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), Lonza (SGX), 3SBIO (HKEx), REPLIGEN CORP (NASDAQ), GENSCRIPT BIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ALKERMES PLC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), CRISPR THERAPEUTICS AG (NASDAQ), GENOMIC HEALTH INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EPIZYME INC (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), OMEROS CORP (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VIVA BIOTECH (HKEx), HOMOLOGY MEDICINES INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), HAOHAI BIOTEC (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ASCLETIS-B (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), RETROPHIN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PERSONALIS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DERMIRA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), ARCUS BIOSCIENCES INC (NYSE), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MERUS B V (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ESSEX BIO-TECH (HKEx), KADMON HLDGS INC (NYSE), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), LEE'S PHARM (HKEx), CASI PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARDELYX INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), MOLECULAR TEMPLATES INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), DPHARMA (Bursa), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), KAMADA (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ENZO BIOCHEM INC (NYSE), X4 PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), APPLIED THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), UNI-BIO GROUP (HKEx), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), BBI LIFE SCI (HKEx), CHIMERIX INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), TREVENA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CEL-SCI CORP (NYSE American), SELECTA BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PORT (SET), NEWLINK GENETICS CORP (NASDAQ), ORGENESIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EQUILLIUM INC (NASDAQ), CURIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ARAVIVE INC (NASDAQ), OTONOMY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), COHBAR INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IBIO INC (NYSE American), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), OUTLOOK THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), REGENT PACIFIC (HKEx), ORGANOVO HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BIOCARDIA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), ALIMERA SCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SENESTECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIOSINO BIO-TEC (HKEx), SOPHIRIS BIO INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TOCAGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), HISTOGENICS CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ISORAY INC (NYSE American), PULMATRIX INCORPORATED (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City^ (SGX), BIONANO GENOMICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), NANOVIRICIDES INC (NYSE American), CLEVELAND BIOLABS INC (NASDAQ), TROVAGENE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CYCLACEL PHARMA IN (NASDAQ), HAO WEN HLDGS (HKEx), PHIO PHARMACEUTICALS CORP (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ADVAXIS INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), MGRC (Bursa), MEGASUN (Bursa), OPGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), QT Vascular (SGX), AIM IMMUNOTECH INC (NYSE American), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.300
-17.44 %
10 Days --0.180
-11.25 %
20 Days --0.220
-13.41 %
Medium Term Return 3 Months -+0.180
+14.52 %
6 Months --0.350
-19.77 %
1 Year -+0.160
+12.70 %
Long Term Return 2 Years -+0.710
+100.00 %
3 Years -+0.900
+173.08 %
5 Years -+1.005
+242.17 %
Annualised Return Annualised --
+27.89 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.940 - 1.870 Change From 1 Year Low +0.480 % Change From 1 Year Low (%) +51.06
Change From 1 Year High -0.450 % Change From 1 Year High (%) -24.06
2 Years Range 0.560 - 1.870 Change From 2 Years Low +0.860 % Change From 2 Years Low (%) +153.57
Change From 2 Years High -0.450 % Change From 2 Years High (%) -24.06
5 Years Range 0.225 - 1.870 Change From 5 Years Low +1.195 % Change From 5 Years Low (%) +531.11
Change From 5 Years High -0.450 % Change From 5 Years High (%) -24.06
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on therapeutic stem cell platform technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2019 1.420 1.420 1.420 1.420 - -
16 Sep 2019 1.535 1.570 1.350 1.420 439,052 -
13 Sep 2019 1.535 1.570 1.350 1.420 439,052 -
12 Sep 2019 1.640 1.665 1.530 1.540 261,775 -
11 Sep 2019 1.685 1.700 1.640 1.660 173,353 -
10 Sep 2019 1.740 1.760 1.680 1.720 173,819 -
09 Sep 2019 1.725 1.750 1.700 1.745 129,420 -
06 Sep 2019 1.700 1.720 1.655 1.720 142,612 -
05 Sep 2019 1.650 1.680 1.640 1.650 89,254 -
04 Sep 2019 1.600 1.665 1.600 1.640 162,055 -
03 Sep 2019 1.640 1.665 1.600 1.600 42,806 -
02 Sep 2019 1.610 1.620 1.600 1.615 57,892 -
30 Aug 2019 1.580 1.680 1.580 1.600 39,542 -
29 Aug 2019 1.510 1.655 1.510 1.640 60,347 -
28 Aug 2019 1.590 1.620 1.550 1.580 94,799 -
27 Aug 2019 1.580 1.620 1.580 1.600 66,461 -
26 Aug 2019 1.650 1.650 1.580 1.600 143,631 -
23 Aug 2019 1.640 1.660 1.640 1.650 58,337 -
22 Aug 2019 1.660 1.680 1.630 1.630 73,481 -
21 Aug 2019 1.650 1.660 1.620 1.650 119,471 -
20 Aug 2019 1.640 1.650 1.620 1.640 19,326 -
19 Aug 2019 1.615 1.660 1.615 1.640 47,767 -
Summary
Current 2 Weeks
(04 Sep 2019 to 17 Sep 2019)
1.600 1.760 1.350 1.420 2,010,392 -
Previous 2 Weeks
(21 Aug 2019 to 03 Sep 2019)
1.650 1.760 1.350 1.600 756,767 -
4 Weeks from
(24 Jul 2019 to 20 Aug 2019)
1.790 1.840 1.350 1.640 3,022,184 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.